The oocyte-to-embryo transition transforms a differentiated germ cell into a totipotent zygote capable of somatic development. In C. elegans, several oocyte proteins, including the meiotic katanin subunit MEI-1 and the oocyte maturation protein OMA-1, must be degraded during this transition [1] . Degradation of MEI-1 and OMA-1 requires the dual-specificity YAK-1-related (DYRK) kinase MBK-2 [2] [3] [4] . Here, we demonstrate that MBK-2 directly phosphorylates MEI-1 and OMA-1 in vitro and that this activity is essential for degradation in vivo. Phosphorylation of MEI-1 by MBK-2 reaches maximal levels after the meiotic divisions, immediately preceding MEI-1 degradation. MEI-1 phosphorylation and degradation still occur in spe-9 eggs, which undergo meiotic maturation and exit in the absence of fertilization [5] . In contrast, MEI-1 phosphorylation and degradation are blocked in cell-cycle mutants that arrest during the meiotic divisions, and are accelerated in wee-1.3(RNAi) oocytes, which prematurely enter meiotic M phase (A. Golden, personal communication). A GFP:MBK-2 fusion relocalizes from the cortex to the cytoplasm during the meiotic divisions, and this relocalization also depends on cellcycle progression. Our findings suggest that regulators of meiotic M phase activate a remodeling program, independently of fertilization, to prepare eggs for embryogenesis.
Results

MBK-2's Kinase Activity Is Essential In Vivo
To characterize the kinase activity of MBK-2, we first tested whether recombinant MBK-2 could phosphorylate a synthetic peptide (DYRKtide) containing the DYRK target consensus RX 1-3 S/TP [6, 7] . Wild-type MBK-2, but not mutant MBK-2 with a mutation in the predicted ATP binding site (K196R), could phosphorylate DYRKtide ( Figure 1A ), consistent with MBK-2 possessing the kinase activity typical of the DYRK family. To determine if kinase activity is essential in vivo, we tested whether MBK-2 and MBK-2(K196R), when fused to green fluorescent protein (GFP), could complement the deletion allele mbk-2(pk1427) [3] . Embryos derived from mbk-2(pk1427) mothers are not viable (0% viability n = 1063). Wild-type GFP:MBK-2 restored viability to 80% (n = 569); in contrast, GFP:MBK-2(K196R) did not rescue (0% viability, n = 198). GFP:MBK-2 and GFP:MBK-2(K196R) were expressed at comparable levels ( Figure S1 in the Supplemental Data available with this article online) and in similar patterns ( Figure 1B ). The only difference was that GFP:MBK-2(K196R) localized to the meiotic spindle in metaphase of meiosis I ( Figure 1B f , arrowhead, 37/66 embryos), whereas GFP:MBK-2 did not (0/43 embryos). We conclude that kinase activity, although not essential for most aspects of GFP:MBK-2 localization, is essential for MBK-2 function in vivo.
MBK-2 Directly Phosphorylates MEI-1 and OMA-1 In Vitro on Sites Required for Degradation In Vivo
Next, we tested whether recombinant MBK-2 could phosphorylate MEI-1, OMA-1, and POS-1, three proteins that require MBK-2 for degradation in vivo [2] [3] [4] . MBP:MBK-2 could phosphorylate MBP:MEI-1 and MBP:OMA-1, but neither MBP:POS-1 nor MBP alone ( Figure 1C ). MBK-2 (K196R) did not phosphorylate any target, confirming that MBK-2 is the active kinase in this assay ( Figure S2A ).
MEI-1 and OMA-1 contain one and two RX 1-3 S/TP consensus sites, respectively, whereas POS-1 does not contain any ( Figure S2B and data not shown). In MEI-1 and OMA-1, one copy of the consensus overlaps with a PEST sequence, a motif commonly found in proteins with high turnover [8] . Disruption of these DYRK sites [MEI-1(S92A) and OMA-1(P240L)] reduced MBK-2's ability to phosphorylate each substrate ( Figure 1C) . We conclude that MBK-2 can phosphorylate MEI-1 and OMA-1 on DYRK consensus sites embedded in PEST sequences (also see below).
OMA-1(P240L) exhibits increased protein stability in vivo and causes embryonic lethality [9, 10] , suggesting that phosphorylation by MBK-2 is required for OMA-1 degradation. To test whether phosphorylation by MBK-2 is also required for MEI-1 degradation, we examined the distribution of MEI-1(S92A) fused to GFP. To avoid the lethality associated with failure to degrade MEI-1, we introduced a second mutation, R36C, to knock out MEI-1 catalytic activity [11, 12] . Like wild-type MEI-1, GFP:MEI-1(R36C) was rapidly degraded during the transition from meiosis to mitosis ( Figure 1D ). In contrast, GFP:MEI-1(R36C,S92A) was maintained past the first mitotic division ( Figure 1D ). We conclude that MBK-2 consensus sites in MEI-1and OMA-1 are required for timely degradation in vivo.
Phosphorylation of MEI-1 by MBK-2 Precedes Degradation In Vivo
To investigate the dynamics of MEI-1 phosphorylation in vivo, we generated an antibody specific for MEI-1 phosphorylated on S92 (P-MEI-1; see Experimental Procedures). Antibody specificity was confirmed with western blots of in vitro-phosphorylated proteins (Figure 2A) and by comparing immunostained wild-type embryos and mutant embryos lacking MEI-1 or MBK-2 (Table S1) . P-MEI-1 was first detected on the maternal chromatin in anaphase of meiosis I ( Figure 2B g , open arrowhead, and Table S2 ). P-MEI-1 in the cytoplasm was first detected during meiosis II and reached peak levels during pronuclear formation (meiotic exit; Figure 2B h-i ). P-MEI-1 levels dropped sharply between pronuclear formation and the first cell division ( Figure 2B i-j ), except in the polar bodies (filled arrowhead, Figure 2B h-j ). Comparison of the relative cytoplasmic intensities of GFP:MEI-1 and P-MEI-1 revealed that (1) the sharp increase in P-MEI-1 levels precedes the decline of GFP:MEI-1 and (2) the disappearance of P-MEI-1 coincides with disappearance of GFP:MEI-1 ( Figure 2C ). Consistent with loss of P-MEI-1 being due to degradation, P-MEI-1 levels remained steady in mel-26(RNAi) embryos, which do not degrade MEI-1 (data not shown). We conclude that phosphorylation of MEI-1 by MBK-2 closely precedes MEI-1 degradation in vivo.
Cell-Cycle Dependence of MEI-1 Phosphorylation and MEI-1 and OMA-1 Degradation In the absence of sperm, C. elegans oocytes arrest in prophase of meiosis I [13] . The sperm-derived MSP peptide activates oocyte maturation, ovulation, and the first meiotic division in the oocyte closest to the spermatheca [14] . Fertilization triggers the second meiotic division and the switch to mitosis [5] . To determine which of these events is required to activate MEI-1 and OMA-1 degradation, we examined mutants defective in fertilization or meiotic progression. We describe results here for GFP:MEI-1, but have also obtained similar data for OMA-1:GFP (data not shown).
spe-9(hc52) hermaphrodites contain sperm that stimulate oocyte maturation but do not fertilize oocytes [15, 16] . Oocytes are ovulated and reach anaphase of the first meiotic division, but eventually exit the meiotic cell cycle without extruding a polar body or forming a meiosis II spindle [5] . We found that GFP:MEI-1 was degraded shortly after ovulation in spe-9(hc52) hermaphrodites ( Figure 3B ). This degradation was dependent on MBK-2, because it was blocked when MBK-2 was depleted by RNAi ( Figure 3C ). Furthermore, we detected robust P-MEI-1 in ovulated spe-9(hc52) eggs with decondensing chromatin ( Figure 3K ). We conclude that fertilization and the second meiotic division are not required for MEI-1 phosphorylation or degradation.
Hermaphrodites that lack the cell-cycle regulators CDK-1 (cyclin-dependent kinase) and MAT-1 (anaphasepromoting complex/cyclosome [APC/C] subunit) ovulate and fertilize oocytes that arrest in prophase of meiosis I (cdk-1) or in metaphase of meiosis I (mat-1) [17] [18] [19] . In both cases, we found that GFP:MEI-1 was not degraded in the arrested embryos ( Figures 3D and E ). In addition, we did not detect P-MEI-1 in mat-1(RNAi) embryos ( Figure 3L ). We conclude that arrest before anaphase I is sufficient to block MEI-1 phosphorylation and degradation even in the presence of fertilization. Depletion of the cullin CUL-2 and the leucine-rich repeat protein ZYG-11 by RNAi delays metaphase of meiosis II for 30-40 min before zygotes eventually exit meiosis and switch to mitosis [20, 21] . Consistent with this temporary arrest, we found that GFP:MEI-1 degradation was delayed in cul-2(RNAi) embryos ( Figure 3F ) and zyg-11(RNAi) embryos (62/68 gonadal arms examined, data not shown). P-MEI-1 levels in metaphase II-arrested cul-2(RNAi) embryos were low and comparable to those measured in wild-type embryos at the same stage (Figure 2C) . Furthermore, cul-2 embryos that progressed past the meiosis II arrest reached only one-third the level of P-MEI-1 compared to wild-type embryos ( Figure 2C ). These results suggest that timely progression through meiosis is required to induce a burst of MEI-1 phosphorylation.
To test whether meiotic progression is sufficient to stimulate MEI-1 degradation, we examined hermaphrodites depleted for the negative regulator WEE-1.3. WEE-1.3 is the C. elegans Myt1 kinase, which inhibits CDK-1 activity by phosphorylation [22] . wee-1.3(RNAi) causes oocytes in the proximal gonad to prematurely enter meiotic M phase (A. Golden, personal communication). We found that GFP:MEI-1 was degraded prematurely in the gonad of wee-1.3(RNAi) hermaphrodites ( Figure 3G ). Furthermore, we detected P-MEI-1 in unovulated oocytes in 9/13 wee-1.3(RNAi) gonads ( Figure 3M ) compared to 0/19 wild-type gonads (data not shown). Premature degradation of GFP:MEI-1 in wee-1.3(RNAi) was dependent on MBK-2 and meiotic progression, because it could be blocked by also depleting MBK-2, CDK-1, or MAT-1 ( Figures 3H-3J ). Taken together, these data suggest that precocious meiotic progression is sufficient to activate MEI-1 phosphorylation and degradation.
Cell-Cycle Dependence of GFP:MBK-2 Dynamics GFP:MBK-2 relocalizes abruptly from the cortex to cortical puncta in anaphase/telophase of meiosis I [3, 5] and progressively from cortical puncta to the cytoplasm during meiosis II and meiotic exit ( Figure 1B a-d ) . Consistent with two distinct steps of relocalization, embryos arrested before or during metaphase I maintain GFP:MBK-2 uniformly at the cortex ( Figures 4B and 4C and [3] ), whereas embryos arrested in metaphase II maintain GFP:MBK-2 in cortical puncta, with some puncta in the cytoplasm ( Figure 4D and 20/24 zyg-11(RNAi) gonads, Table S2 ). P-MEI-1 staining was also detected in polar bodies (B h-j , arrowheads). PN denotes pronuclear. (C) Graph of GFP:MEI-1 and P-MEI-1 levels in wild-type and cul-2(RNAi) embryos from metaphase of meiosis I through the 2-cell stage. Two vertical red lines on the x axis represent the point in meiosis where cul-2(RNAi) mutants temporarily arrest. Values plotted are the mean value 6 standard error (see Experimental Procedures). PN denotes pronuclear.
data not shown). In spe-9 eggs, GFP:MBK-2 progressed from the cortex into cortical puncta and the cytoplasm as in wild-type embryos, suggesting that meiotic exit, rather than meiosis II, is critical ( Figure 4E and [5] ). In wee-1.3(RNAi) oocytes, relocalization of GFP:MBK-2 to cortical puncta and to the cytoplasm occurred precociously in oocytes ( Figure 4F and A. Golden, personal communication). This premature relocalization was blocked by CDK-1 and MAT-1 depletion (Figures 4G  and 4H ). We conclude that GFP:MBK-2 relocalizes from the cortex to the cytoplasm in a two-step process linked to progression past metaphase I and possibly to meiotic exit.
Discussion
Phosphorylation by MBK-2 Marks Oocyte Proteins for Degradation
Several observations support the hypothesis that phosphorylation by MBK-2 triggers MEI-1 degradation at meiotic exit. First, MBK-2 phosphorylates MEI-1 on S92 directly in vitro. Second, S92 is phosphorylated in vivo, and this phosphorylation requires MBK-2. Third, S92 phosphorylation immediately precedes MEI-1 degradation. Finally, substitution of S92 with the nonphosphorylatable amino acid alanine blocks MEI-1 degradation.
How does phosphorylation stimulate MEI-1 destruction? Degradation of MEI-1 depends on recognition by MEL-26, the substrate recruitment factor for the E3 ubiquitin ligase MEL-26/CUL-3 [1] . The expression pattern of MEL-26 is not yet known, but one possibility is that phosphorylation by MBK-2 increases the affinity of MEI-1 for MEL-26 or the MEL-26/CUL-3 complex at meiotic exit. For example, phosphorylation of Sic1p by cyclin/Cdk stimulates its recognition by Cdc4p during the G1/S transition in S. cerevisiae [23] . Whether MEI-1 needs to be phosphorylated to interact with MEL-26 in vivo remains to be determined.
MBK-2 also phosphorylates OMA-1 in vitro on a site essential for degradation in vivo, suggesting that OMA-1 is a second MBK-2 target. Nishi and Lin [24] [24] , just as we report here for MEI-1. Unlike MEI-1, however, OMA-1 is not degraded until after the first mitosis. Consistent with this delay, OMA-1 degradation also requires phosphorylation by a second kinase [24] .
The human DYRK kinase DYRK1B/Mirk has also been reported to destabilize target proteins. During differentiation of C2C12 myoblasts, DYRK1B/Mirk phosphorylates cyclin D1, leading to its destruction and G 0 /G 1 cellcycle arrest [26] . Other DYRK1B/Mirk targets, however, have been reported to become stabilized or to change localization following phosphorylation [27] [28] [29] . Together with our findings, these studies suggest that a common role for DYRK kinases may be to facilitate developmental transitions by modifying the stability and/or localization of multiple target proteins in differentiating cells.
Activators of Meiotic M Phase Stimulate Oocyte-Protein Degradation
Transition from an oocyte to an embryo requires completion of the meiotic divisions and fertilization. In most animals, oocytes are released from prophase arrest by maturation and progress until a second arrest point (typically metaphase I or II), pending fertilization [30] . Calcium signaling at fertilization releases oocytes from this second arrest, allowing completion of the meiotic divisions and meiotic exit [31] . In this respect, C. elegans differs from most commonly studied model systems because fertilization is not required for meiotic exit [5] . Unfertilized, matured oocytes arrest temporarily in anaphase I, but eventually exit meiosis without forming a second meiotic spindle [5] . This unusual property allowed us to determine whether meiosis or fertilization is most directly required for MBK-2-dependent events. We found that meiotic maturation, rather than fertilization, is necessary and sufficient to induce MEI-1 phosphorylation and degradation. At this point, we do not know whether MEI-1 phosphorylation is activated as a secondary consequence of meiotic maturation or depends more directly on a specific cell-cycle activator of meiotic M phase. MEI-1 phosphorylation is first detected on the meiotic spindle in anaphase of meiosis I, with peak levels reached by meiotic exit. OMA-1 phosphorylation also first peaks at meiotic exit [24] , suggesting that this timing is specified by a property intrinsic to MBK-2 rather than its substrates.
How is MBK-2 activated during meiotic progression? A GFP:MBK-2 fusion relocalizes from the cortex, to cortical puncta, and to the cytoplasm during the meiotic division. Because MEI-1 and OMA-1 are both cytoplasmic proteins, an attractive possibility is that release of MBK-2 from the cortex allows it to reach its targets. Examination of the localization dynamics of endogenous MBK-2 will be necessary before this hypothesis can be explored further. Nevertheless, the finding that GFP:MBK-2 relocalizes in a cell-cycle-dependent manner supports the view that meiotic progression elicits significant changes throughout the egg. We suggest that the meiotic cellcycle machinery activates an egg-wide remodeling program that facilitates the transition from a differentiated germ cell to a totipotent zygote.
Experimental Procedures
Nematode Strains, Lethality Analysis, and Temperature-Shift Experiments C. elegans strains (Table S3) were derived from the wild-type Bristol strain N2 and reared with standard procedures [32] . mat-1(ax227) and spe-9(hc52) hermaphrodites were maintained at 16ºC and shifted to 25ºC as L4 larvae and as embryos, respectively.
RNAi-Mediated Interference
RNAi-mediated interference (RNAi) was performed with the feeding method [33] , as described in [3, 34] . cdk-1, mat-1, wee-1.3, and mel-26 RNAi clones were obtained from the Ahringer RNAi library [35] , cul-2 from [36] , and mbk-2 from [3] .
Cloning and Transgenics
Gateway cloning (Invitrogen) was used to generate all constructs [37] . Coding sequences were PCR amplified from cDNA and cloned into pDONR201. pDONR constructs were recombined into pID3.01B (for N-terminal GFP fusion proteins), pCD1.01 (for RNAi feeding experiments), or pJP1.09 (for N-terminal maltose binding protein fusions). Point mutations in the MEI-1 and OMA-1 coding sequences were introduced in the pDONR constructs with the QuikChange Site-Directed Mutagenesis Kit (Stratagene). GFP lines were generated by the microparticle bombardment method [38] .
Expression and Partial Purification of MBP Fusion Proteins MBP fusions were grown in E. coli strain CAG456 and induced with 300 mM isopropyl-b-D-1-thiogalactopyranoside (IPTG) overnight at 15ºC. Bacterial pellets were washed and resuspended in 10 ml icecold column buffer (20 mM Tris-HCl, 500 mM NaCl, 1 mM EDTA, 1 mM 1,4-Dithio-DL-threitol [DTT], 10% glycerol), passed once through a French Press, and centrifuged (SW41 rotor at 36,000 RPM, SA300 rotor at 20,000 RPM, or equivalent, for 30 min).
MBP fusions were partially purified from cleared lysates by affinity chromatography (amylose resin, New England Biolabs) and eluted with 250 ml column buffer plus 10 mM maltose. Eluates were stored at 280ºC. Kinase assays were performed as in [39] .
Immunoblotting
One hundred and twenty-five hermaphrodites for each genotype in Figure S1 were collected into 7.5 ml distilled water and frozen in a dry-ice/ethanol bath. Two and a half microliters of 43 NuPAGE LDS sample buffer and 0.5 ml 1M DTT were added to each tube, and the samples were boiled at 100ºC for 5 min before loading. The proteins were separated on a 4%-12% NuPAGE gel (Invitrogen) and transferred to a nitrocellulose (Schleicher & Schuell) membrane [40] . The membrane was blocked in 13 PBS, 0.1% Tween-20 (PBSTw) containing 10% (w/v) nonfat dry milk (NFDM, BioRad) for 1 hr at room temperature and incubated with a-GFP antibody (JL-8 1:1000 dilution, BD Biosciences) in PBSTw plus 5% (w/v) NFDM overnight at 4ºC. The membrane was washed in PBSTw 3 3 10 min and incubated with HRP-conjugated secondary (sheep a-mouse [Amersham, NA931V], 1:10,000 dilution) in PBSTw at room temperature for 1 hr, followed by three 10 min washes in PBSTw and ECL detection. Western blotting to detect MBP:MBK-2 in Figure 1A was performed as above with a-MBP antibody (#E8032S 1:10,000 dilution, NEB).
Generation of Phosphospecific MEI-1 Antibody, Western Blotting, and Immunostaining Rabbit polyclonal antibody 129091/P3 was raised against peptide CAMTRQSGS(PO3)PEPPA and affinity purified (Bethyl Laboratories). For the western blot in Figure 2A , procedures were performed as in Immunoblotting, above, with the following antibodies and dilutions: 129091/P3 (1:2000), HRP-conjugated donkey anti-rabbit IgG (Jackson #711-035-152) (1:10,000). For immunostaining, embryos were fixed as described in [41] and incubated with 129091/P3 (1:2000 dilution) overnight at room temperature, followed by Alexa 568-conjugated goat anti-rabbit secondary antibody (1:250 dilution, Molecular Probes).
Microscopic Imaging and Quantitation
Images were acquired with a Hamamatsu ORCA-ER digital camera attached to a Zeiss Axioplan 2 equipped with Ludl shutters and a mercury lamp. Pictures were acquired and processed with IPLab software (Scanalytics) and merged and cropped in Photoshop CS.
Images used for the graph in Figure 2C were collected with 0.125 s exposure, and in all cases, the raw pixel values were within the range of the CCD camera (0-4095). Using IPLab, we measured the average pixel intensity for a 70 3 70 pixel region within each embryo and corrected it for background staining by subtracting the average value obtained from 4-cell or older embryos on the same slide. Backgroundcorrected values from three or more same-stage embryos (except cul-2(RNAi), Metaphase I where n = 1) were averaged and scaled such that the lowest average value (e.g., Metaphase I for P-MEI-1 staining) equals 0 and the maximal value (e.g., Pronuclear Formation for P-MEI-1 staining) equals 1. Embryos were staged by DAPI staining.
Supplemental Data
Supplemental Data include two figures and three tables and are available with this article online at: http://www.current-biology. com/cgi/content/full/16/1/56/DC1/.
